Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities
Cambridge, MA, July 25, 2018 - Carilion Clinic, a not-for-profit healthcare organization serving nearly one million residents in western Virginia, has joined the TriNetX global health research network to better assess its patient population for the feasibility of performing robust clinical trials.
“We want to enhance our ability to quickly execute clinical research trials with external partners to provide access to cutting edge therapeutics and devices to our patients,” said Francis X. Farrell, Ph.D., Senior Director, Research and Development at Carilion. “We envision that our research community will utilize TriNetX to explore potential areas of further research and collaboration with other members of the network.”
TriNetX’s cloud-based platform, TNX™, provides on-demand access to longitudinal clinical data and a set of highly intuitive analytics capabilities, enabling researchers to design successful protocols, improve site selection and planning, and create real-world evidence. TriNetX has partnered with leading healthcare organizations spanning 15 countries to create a global health research network representing over 100 million patients.
TriNetX implements and configures hardware and software into a member organization’s IT infrastructure that often builds on existing data resources such as i2b2 and Observational Medical Outcomes Partnership (OMOP). Researchers then have access to the institution’s de-identified patient data through a user-friendly interface and a growing number of visualization and analysis capabilities.
To date, TriNetX has been used to analyze over 6,700 protocols, has presented over 1,500 clinical trial opportunities to its healthcare members and has been used for over 75 Real-World Evidence (RWE) studies.
“Healthcare is a rapidly evolving discipline that is becoming more driven by quick access to medical information generated by hospitals, academic medical centers, research institutes, and private entities such as pharmaceutical and biotechnology companies,” Farrell continued. “This platform will give us the opportunity to expedite our clinical research and benefit from engaging with peers through TriNetX’s network.”
Headquartered in Roanoke, VA, Carilion is a large, integrated healthcare delivery network that owns and operates seven hospitals in western Virginia, more than 225 outpatient practices, and Jefferson College of Health Sciences. Carilion also has a unique private-public partnership with Virginia Tech, creating the Virginia Tech Carilion School of Medicine and Research Institute (VTC). Carilion is home to the area’s only Level 1 trauma center and has more than 13,000 employees and nearly 750 physicians covering more than 75 specialties.
“We are pleased that Carilion has joined the TriNetX community,” said Gadi Lachman, CEO of TriNetX. “We are confident we can help them reach their goals of expanding their exposure to clinical trials and increasing collaboration opportunities across institutions.”
####
About Carilion Clinic
Carilion Clinic is a not-for-profit healthcare organization based in Roanoke, VA. Through their comprehensive network of hospitals, primary and specialty physician practices and other complementary services, Carilion provides quality care close to home for nearly one million Virginians. With an enduring commitment to the health of their region, they also seek to advance care through medical education and research, help the community stay healthy and inspire the region to grow stronger. For more information, visit Carilion’s website at https://www.carilionclinic.org
About TriNetX
TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real-time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. For more information, visit TriNetX at http://www.trinetx.com or follow @TriNetX on Twitter.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
